Hydrix Limited announce a number of senior appointments to strengthen the Company's leadership capability to support the anticipated continued strong growth and the successful execution of the Company's strategy. Gavin Coote, currently non-executive Chairman, will assume the role of Executive Chairman effective 1 January 2020. In this role, Gavin will be responsible for driving the Company's continued growth and leading the execution of its strategy. Since joining the Board as Chairman in January 2017, Gavin has overseen the transformation of the Company. Gavin brings over 25 years of executive and board leadership experience, gained in the USA and Australia, working at companies with revenues of up to $1 billion across diverse industries. He has led a number of companies through organic and acquisition-based growth strategies, culminating in strong shareholder returns. Peter Lewis will transition to the role of Executive Vice President Corporate Development, effective 1 January 2020, reporting to the Executive Chairman. In this newly created global corporate development role, Peter will originate large-scale product design and engineering services contracts and work with the leadership team to execute the Company's buy, build, invest strategy. Michael Trieu has been promoted to General Manager Hydrix Services, to lead the Group's product development and services division. Michael has over 17 years of research & development and product delivery experience in implantable medical devices and medical device engineering consulting. His previous leadership positions include roles with Cochlear, where he was team leader in design and development of implants across multiple regulatory regions, and Nanosonics, as engineering manager. Paul Kelly has joined the Company in a newly created position of interim General Manager Cardiac Products, initially responsible for developing a regulatory and go to market strategy for the Asia Pacific distribution of Angel Medical's Guardian System. In addition, Paul will join the Company's recently established Medical Advisory Board.